Diphenyl quinolines and isoquinolines: Synthesis and primary biological evaluation

被引:109
作者
Croisy-Delcey, M
Croisy, A
Carrez, D
Huel, C
Chiaroni, A
Ducrot, P
Bisagni, E
Jin, L
Leclercq, G
机构
[1] Ctr Univ Orsay, Lab Raymond Latarjet, Inst Curie Rech, UMR 176 CNRS, F-91405 Orsay, France
[2] Ctr Univ Orsay, Inst Curie Rech, U350 INSERM, F-91405 Orsay, France
[3] CNRS, Inst Chim Subst Nat, F-91198 Gif Sur Yvette, France
[4] Inst Jules Bordet, Serv Med Interne, Lab JC Heuson Cancerol Mammaire, B-1000 Brussels, Belgium
关键词
D O I
10.1016/S0968-0896(00)00194-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The synthesis of a series of 35 substituted 3,4-diphenyl quinolines and isoquinolines is described. The majority of these molecules differ from all other triphenylethylene based antiestrogens by a different spatial location of the aminoalkyl side chain. The binding affinity of the most representative molecules (8, 9, 19, 20, 21, 23 and 25), including analogues 8 and 21 without the side chain, for the estrogen receptor alpha (ER)(dagger) was determined. The ability of these molecules to induce the progesterone receptor was also studied. Antiproliferative activity was evaluated on MCF-7 human breast cancer cells, while intrinsic cytotoxic/cytostatic properties resulting from interaction with other targets than ER were assayed on L1210 murine leukemia cells. Introduction of an aminoalkylamino side chain at carbon 2 confers strong cytotoxic properties to diphenylquinolines 9 and 10 as well as pure antiestrogenic activities. However, cytotoxicity is so high with respect to antiestrogenicity that the latter was clearly observable only in one case (9b). The structure of compound 9b was determined by X-ray crystallography. Molecular modeling of its docking within the hormone-binding domain of the receptor was subsequently undertaken. According to our results, the design of molecules with the side chain bound to the ethylene part of the triphenyl ethylene skeleton might generate compounds of potential pharmacological interest, (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:2629 / 2641
页数:13
相关论文
共 42 条
  • [1] The estradiol pharmacophore: Ligand structure-estrogen receptor binding affinity relationships and a model for the receptor binding site
    Anstead, GM
    Carlson, KE
    Katzenellenbogen, JA
    [J]. STEROIDS, 1997, 62 (03) : 268 - 303
  • [2] BERTI G, 1958, GAZZ CHIM ITAL, V88, P704
  • [3] EVALUATION OF ESTROGEN-RECEPTOR, ANTIESTROGEN BINDING-SITES AND CALMODULIN FOR ANTIESTROGEN RESISTANCE OF 2 CLONES DERIVED FROM THE MCF-7 BREAST-CANCER CELL-LINE
    BORRAS, M
    JIN, L
    BOUHOUTE, A
    LEGROS, N
    LECLERCQ, G
    [J]. BIOCHEMICAL PHARMACOLOGY, 1994, 48 (11) : 2015 - 2024
  • [4] Molecular basis of agonism and antagonism in the oestrogen receptor
    Brzozowski, AM
    Pike, ACW
    Dauter, Z
    Hubbard, RE
    Bonn, T
    Engstrom, O
    Ohman, L
    Greene, GL
    Gustafsson, JA
    Carlquist, M
    [J]. NATURE, 1997, 389 (6652) : 753 - 758
  • [5] Carcangiu M L, 1997, Anat Pathol, V2, P53
  • [6] VALIDATION OF THE GENERAL-PURPOSE TRIPOS 5.2 FORCE-FIELD
    CLARK, M
    CRAMER, RD
    VANOPDENBOSCH, N
    [J]. JOURNAL OF COMPUTATIONAL CHEMISTRY, 1989, 10 (08) : 982 - 1012
  • [7] Clark M., 1990, TETRAHEDRON COMPUT M, V3, P47, DOI DOI 10.1016/0898-5529(90)90120-W
  • [8] CROISYDELCEY M, 1995, HETEROCYCLES, V41, P1721
  • [9] FAYE JC, 1983, P NATL ACAD SCI-BIOL, V80, P3158, DOI 10.1073/pnas.80.11.3158
  • [10] Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study
    Fisher, B
    Costantino, JP
    Wickerham, DL
    Redmond, CK
    Kavanah, M
    Cronin, WM
    Vogel, V
    Robidoux, A
    Dimitrov, N
    Atkins, J
    Daly, M
    Wieand, S
    Tan-Chiu, E
    Ford, L
    Wolmark, N
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) : 1371 - 1388